These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26775690)

  • 21. Diagnostic Biomarkers in Oral Verrucous Carcinoma: A Systematic Review.
    Hosseinpour S; Mashhadiabbas F; Ahsaie MG
    Pathol Oncol Res; 2017 Jan; 23(1):19-32. PubMed ID: 27924463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel genomic signature reclassifies an oral cancer subtype.
    Samman M; Wood HM; Conway C; Stead L; Daly C; Chalkley R; Berri S; Senguven B; Ross L; Egan P; Chengot P; Ong TK; Pentenero M; Gandolfo S; Cassenti A; Cassoni P; Al Ajlan A; Samkari A; Barrett W; MacLennan K; High A; Rabbitts P
    Int J Cancer; 2015 Nov; 137(10):2364-73. PubMed ID: 26014678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical evaluation of type IV collagen and laminin-332 γ2 chain expression in well-differentiated oral squamous cell carcinoma and oral verrucous carcinoma: a new recommended cut-off.
    Zargaran M; Eshghyar N; Vaziri PB; Mortazavi H
    J Oral Pathol Med; 2011 Feb; 40(2):167-73. PubMed ID: 21158930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunohistochemical and ultrastructural study of basement membrane in oral verrucous carcinoma].
    Jiang L; Wang S; Chen X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Jul; 36(4):308-10. PubMed ID: 11718019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma.
    Iamaroon A; Krisanaprakornkit S
    Oral Oncol; 2009 Oct; 45(10):e175-9. PubMed ID: 19628421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The stromal immunoexpression of CLIC4 may be related to the difference in the biological behavior between oral squamous cell carcinoma and oral verrucous carcinoma.
    Xerez MC; Barros CC; Queiroz SI; Silveira ÉJ; Costa AD
    Med Oral Patol Oral Cir Bucal; 2023 Sep; 28(5):e418-e424. PubMed ID: 37026609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidant enzymes in oral verrucous carcinoma.
    Fu TY; Tsai MH; Wang JS; Ger LP
    J Oral Pathol Med; 2017 Jan; 46(1):46-49. PubMed ID: 27245640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
    Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
    Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of cellular proliferation in oral verrucous carcinoma and well-differentiated oral squamous cell carcinoma using Ki67: a non-reliable factor for differential diagnosis?
    Zargaran M; Eshghyar N; Baghaei F; Moghimbeigi A
    Asian Pac J Cancer Prev; 2012; 13(11):5811-5. PubMed ID: 23317261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
    Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A
    Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gene expression profile changes in oral verrucous carcinoma and oral squamous cell carcinoma].
    Tang ZG; Zhao SP; Zhang L; Li XL
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Apr; 42(4):229-30. PubMed ID: 17683672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
    Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
    J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PI3K/AKT Signaling Pathway Mediated Autophagy in Oral Carcinoma - A Comprehensive Review.
    Rajendran P; Sekar R; Dhayasankar PS; Ali EM; Abdelsalam SA; Balaraman S; Chellappan BV; Metwally AM; Abdallah BM
    Int J Med Sci; 2024; 21(6):1165-1175. PubMed ID: 38774756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
    Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
    BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the Akt/mTOR pathway in dentigerous cysts, odontogenic keratocysts, and ameloblastomas.
    Chaisuparat R; Yodsanga S; Montaner S; Jham BC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):336-42. PubMed ID: 23953418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of BDNF/TrkB/Akt pathway is associated with aggressiveness and unfavorable survival in oral squamous cell carcinoma.
    Moraes JK; Wagner VP; Fonseca FP; Amaral-Silva GKD; de Farias CB; Pilar EFS; Gregianin L; Roesler R; Vargas PA; Martins MD
    Oral Dis; 2019 Nov; 25(8):1925-1936. PubMed ID: 31498938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the Akt/mammalian target of rapamycin pathway in myxofibrosarcomas.
    Takahashi Y; Kohashi K; Yamada Y; Endo M; Setsu N; Ishii T; Yamamoto H; Iwamoto Y; Oda Y
    Hum Pathol; 2014 May; 45(5):984-93. PubMed ID: 24746202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy.
    Fang L; Wang H; Zhou L; Yu D
    Oral Oncol; 2011 Jan; 47(1):16-21. PubMed ID: 21109483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
    Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
    Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.